financetom
Business
financetom
/
Business
/
Blueprint Medicines Insider Sold Shares Worth $4,136,328, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Blueprint Medicines Insider Sold Shares Worth $4,136,328, According to a Recent SEC Filing
Jun 4, 2024 1:32 PM

04:10 PM EDT, 06/04/2024 (MT Newswires) -- L. Becker Hewes, Chief Medical Officer, on May 31, 2024, sold 39,030 shares in Blueprint Medicines ( BPMC ) for $4,136,328. Following the Form 4 filing with the SEC, Hewes has control over a total of 31,938 shares of the company, with 31,938 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1597264/000141588924015315/xslF345X03/form4-06042024_040602.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cronos Group Shares Fall After Posting Swing to Q4 Loss, Net Revenue Gain
Cronos Group Shares Fall After Posting Swing to Q4 Loss, Net Revenue Gain
Mar 11, 2026
09:34 AM EST, 02/26/2026 (MT Newswires) -- Cronos Group's ( CRON ) shares were down nearly 6% in early Thursday trading after the company reported a Q4 net loss premarket of $0.02 per diluted share, swinging from earnings of $0.11 a year earlier. Three analysts polled by FactSet expected earnings of $0.02. Net revenue for the quarter ended Dec. 31...
CAVU Resources, Inc. (CAVR) Announces Formal Closing of Merger Agreement with PostBidShip., Inc. Awaits FINRA Notification of Share Distribution Record Date
CAVU Resources, Inc. (CAVR) Announces Formal Closing of Merger Agreement with PostBidShip., Inc. Awaits FINRA Notification of Share Distribution Record Date
Mar 11, 2026
TULSA, OK / ACCESS Newswire / March 11, 2026 / CAVU Resources, Inc. (CAVR or the Company) is pleased to announce that, consistent with its strategic roadmap and commitment to shareholders, it has officially signed and closed the Agreement and Plan of Merger between its subsidiary, PBS Recon, Inc., and PostBidShip., Inc. (PBS). With the execution and closing of this...
Docebo Inc. Announces Results of its Substantial Issuer Bid
Docebo Inc. Announces Results of its Substantial Issuer Bid
Mar 11, 2026
TORONTO--(BUSINESS WIRE)-- Docebo Inc. ( DCBO ) , a AI workforce readiness platform that connects skills intelligence, learning execution, and measurable outcomes, announced today the results of its substantial issuer bid (the “Offer”) to repurchase for cancellation up to US$60,000,000 of its outstanding common shares (the “Common Shares”) at a price of US$20.40 per Common Share. The Offer expired at...
ORAGENICS EXPLORES EXPANSION OF CNS PLATFORM PURSUING ACQUISTION OF ASSETS IN BRAIN HEALTH, RECOVERY, AND NEUROPROTECTION
ORAGENICS EXPLORES EXPANSION OF CNS PLATFORM PURSUING ACQUISTION OF ASSETS IN BRAIN HEALTH, RECOVERY, AND NEUROPROTECTION
Mar 11, 2026
SARASOTA, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. ( OGEN ) , a clinical-stage biotechnology company pioneering brain-targeted therapeutics through proprietary intranasal delivery technology, today announced that it is exploring discussions with third parties regarding the potential acquisition of additional assets in the central nervous system (CNS) space, with a specific focus on brain health and brain recovery...
Copyright 2023-2026 - www.financetom.com All Rights Reserved